Skip to main content
. 2024 Jun 20;8:e2300184. doi: 10.1200/CCI.23.00184

FIG 2.

FIG 2.

Decision curve analysis for CAPRA-S, CCHE, and CCHEK. CCHEK has the most net benefit compared with other methods. CAPRA-S, Cancer of the Prostate Risk Assessment Post-Surgical; CCHE, CAPRA-S + CNN H&E; CCHEK, CAPRA-S + CNN H&E & Ki-67.